Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

Inclusion Criteria: * Female 21 years or older (ASC-US study only) * Female 30 years or older (Adjunct and ASC-US studies) * Subject attending a participating clinic and undergoing a Pap screening exam during the clinic visit * Ability to comprehend and sign an IRB-approved Informed Consent Form Exclusion Criteria: * Diagnosis of cervical disease (cancer or precancerous condition) in the past 12 months * Abnormal Pap test result in the past 12 months * Subject under 18 years of age and consenting to the study without the presence of their parent or legal guardian * Known to be pregnant * Having an illness or medical condition that could interfere with or affect the conduct, results, and/or completion of the clinical trial * Having an illness or medical condition that the investigator or physician feels would create an unacceptable risk to the subject if she enrolled into the clinical trial * Prior vaccination for HPV